ML Bio Solutions, Inc. clinical trials
Acquired by BridgeBio, Jul 2019 · source ↗
The registry lists 4 studies whose lead sponsor is ML Bio Solutions, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 9, 2026.
Before and after it joined BridgeBio
- First submitted before ML Bio Solutions, Inc. became part of BridgeBio
- 0
- First submitted after ML Bio Solutions, Inc. became part of BridgeBio
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- ML Bio Solutions, Inc.4 studies
Something wrong with this grouping? Tell us on the BridgeBio page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All BridgeBio studies →
- Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)Active, not recruitingNCT05775848Phase 3
Sponsor listed in the registry: ML Bio Solutions, Inc. · First submitted after ML Bio Solutions, Inc. became part of BridgeBio
- Study of BBP-418 in Patients With LGMD2IActive, not recruitingNCT04800874Phase 2
Sponsor listed in the registry: ML Bio Solutions, Inc. · First submitted after ML Bio Solutions, Inc. became part of BridgeBio
- Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9Active, not recruitingNCT07678775Phase 3
Sponsor listed in the registry: ML Bio Solutions, Inc. · First submitted after ML Bio Solutions, Inc. became part of BridgeBio
- Biomarker Development in LGMD2iCompletedNCT04202627
Sponsor listed in the registry: ML Bio Solutions, Inc. · First submitted after ML Bio Solutions, Inc. became part of BridgeBio